Browse studies, page 784

Page 784 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.

• Early Intervention, Randomized, Mulitcenter, Placebo-Controlled, 4-Period Crossover, Multi-Attack Study to Evaluate Efficacy & Safety of ComboProduct Containing Sumatriptan and Naproxen Sodium for Acute Treatment of Migraine in Adolescents ClinicalTrials.gov · COMPLETED, 2014
• A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group Trial to Evaluate Early Efficacy and Tolerability of Zolmitriptan (ZOMIG) Nasal Spray in the Acute Treatment of Adult Subjects With Migraine ClinicalTrials.gov · COMPLETED, 2003
• Candesartan vs Propranolol for Migraine Prevention: A Double Blind, Placebo Controlled, Double Dummy, Triple Cross-over Study ClinicalTrials.gov · COMPLETED, 2012
• The Role of Osteopathic Manipulation in the the Management of Post-traumatic Migraine ClinicalTrials.gov · COMPLETED, 2019
• A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial Evaluating the Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic Migraine ClinicalTrials.gov · COMPLETED, 2019
• Occipital Nerve Stimulation (ONS) for Migraine OPTIMISE ClinicalTrials.gov · TERMINATED, 2017
• Proof-of-concept Study to Demonstrate Inhibition of Prostaglandin E (PGE) Production and Associated Biological Effects in the Lower Respiratory Tract by Ibuprofen ClinicalTrials.gov · COMPLETED, 2018
• An Open-label Study of Eletriptan for the Acute Treatment of Migraine in Migraine Sufferers Who Are Dissatisfied With Rizatriptan Therapy ClinicalTrials.gov · COMPLETED, 2003
• Use of a Treatment Benefit Questionnaire in Patients With Chronic Migraine Treated With OnabotulinumtoxinA (BOTOX®) ClinicalTrials.gov · COMPLETED, 2014
• Utility of a Novel, Combined Biofeedback-Virtual Reality Device as Adjunctive Treatment for Chronic Migraine ClinicalTrials.gov · COMPLETED, 2022
• Timolol Eye Drops in the Treatment of Acute Migraine Headache ClinicalTrials.gov · TERMINATED, 2017
• Efficacy of Inhaled Cannabis Versus Placebo for the Acute Treatment of Migraine: a Randomized, Double-blind, Placebo-controlled, Crossover Trial ClinicalTrials.gov · COMPLETED, 2023
• An Innovative Psychosocial Intervention for the Treatment of Chronic Pain Patients and Their Families ClinicalTrials.gov · COMPLETED, 2016
• A Phase II Study of Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Locally Advanced or Primary Metastatic Breast Cancer ClinicalTrials.gov · TERMINATED, 2011
• Pituitary Adenylate Cyclase-activating Polypeptide (PACAP27) Headache Properties in Migraine Without Aura Patients ClinicalTrials.gov · COMPLETED, 2018
• Benign Paroxysmal Positional Vertigo (BPPV) Training for Sports Medicine Providers in a Pediatric Concussion Program ClinicalTrials.gov · COMPLETED, 2023
• Comparison Study of the Effectiveness Between Syndrome Differentiation Treatments and Fixed Formula Treatment for Perimenopausal Syndrome With Chinese Herbal Medicine ClinicalTrials.gov · COMPLETED, 2023
• An Open-labeled Trial of Ramipril in Patients With Migraine ClinicalTrials.gov · COMPLETED, 2005
• A Randomized, Sham-controlled Trial of Greater Occipital Nerve Block as Second Line Therapy for ED Patients With Acute Migraine ClinicalTrials.gov · COMPLETED, 2018
• Discharge Educational Strategies for Reduction of Vascular Events ClinicalTrials.gov · COMPLETED, 2019
• Single-Blind, Randomized, Controlled Pilot Trial of a Cognitive-Behavioral Therapy Digital Therapeutic Delivered Online for Post-Traumatic Headaches in Adults With History of Concussive Traumatic Brain Injury ClinicalTrials.gov · COMPLETED, 2026
• A Single-center, Open-label, Clinical Effect Observational Study to Evaluate the Safety and Effectiveness of Reducing the Frequency of Migraine Onset Through Clinical Application of Elexir (Trigeminal Nerve Electrical Stimulator) in Migraine Patients ClinicalTrials.gov · COMPLETED, 2022
• Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome: A Phase II Trial ClinicalTrials.gov · COMPLETED, 2022
• A Pilot, Open-Label Study to Assess the Effect of Galcanezumab-gnlm in Reducing the Frequency and Severity of Post-Traumatic, Migrainous Headaches ClinicalTrials.gov · COMPLETED, 2024
• CGRP Induced Migraine Attacks in Patients With High and Low Genetic Load ClinicalTrials.gov · COMPLETED, 2013
• An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate) Injection 4mg Administered Using the IMITREX STATdose System® and a TREXIMA Tablet Followed by IMI ClinicalTrials.gov · COMPLETED, 2008
• Biofeedback EMG Alternative Therapy for Chronic Low Back Pain and Chronic Cancer Pain (BEAT-Pain): A Pilot Efficacy Study ClinicalTrials.gov · COMPLETED, 2023
• Randomized, Double-blind, Comparative-effectiveness Study Comparing Corticosteroid Injections to Pulsed Radiofrequency for Occipital Neuralgia ClinicalTrials.gov · COMPLETED, 2015
• Oral Caffeine Decreases the Frequency of Opioid Demand in AIS Patients After Spinal Fusion ClinicalTrials.gov · COMPLETED, 2024
• A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention ClinicalTrials.gov · COMPLETED, 2019
• The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache. Development of a Pragmatic Migraine Model ClinicalTrials.gov · COMPLETED, 2015
• Randomized, Double Blind Clinical Trial to Study the Effect of Cannabidiol (CBD) 133mg + Cannabigerol (CBG) 66mg + Tetrahydrocannabinol (THC) 4mg a Day As Adjunctive Therapy in the Treatment of Chronic Migraine - CAMTREA TRIAL ClinicalTrials.gov · TERMINATED, 2025
• Randomized, Double-Blind, Study to Assess Low-Dose Naltrexone and Acetaminophen Combination in the Prevention of Episodic Migraine in Adults ClinicalTrials.gov · COMPLETED, 2018
• RELAXaHEAD for Headache Patients (Phase I) ClinicalTrials.gov · COMPLETED, 2019
• Study of Key Electro-acupuncture Technique on Migraine ClinicalTrials.gov · COMPLETED, 2017
• OnabotulinumtoxinA for Chronic Headaches: Is 155 Units Superior to 100 Units? ClinicalTrials.gov · TERMINATED, 2022
• An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache ClinicalTrials.gov · COMPLETED, 2007
• A Comparison of the Efficacy and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) Versus Placebo for the Acute Treatment of Migraine Headache Pain ClinicalTrials.gov · COMPLETED, 2003
• Distinct Mechanisms of Cognitive Behavioral Therapy Effects in Youth With Migraine & Dissecting Neural Mechanisms Supporting Mind and Body Approaches to Pain Reduction in Youth With Migraine ClinicalTrials.gov · COMPLETED, 2025
• Evaluation of Efficacy and Safety of add-on Alpha-lipoic Acid on Migraine Prophylaxis in Adolescent Population: A Randomized Controlled Trial ClinicalTrials.gov · COMPLETED, 2021
• Medication Overuse Headaches: the Impact of Educative Telephone Coaching Administered by Nurses Prior to the Medical Appointment in a Tertiary Consultation Center: a Comparative Randomized Trial ClinicalTrials.gov · COMPLETED, 2012
• A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Single Attack Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine ClinicalTrials.gov · COMPLETED, 2018
• IV Valproate for Acute Migraine. A Randomized Comparison Versus IV Metoclopramide and IV Ketorolac ClinicalTrials.gov · COMPLETED, 2013
• Intra-Arterial Injection of Lidocaine and Glucocorticoid in the Treatment of Intractable Headaches: A Non-Randomized, Open-Label Phase 1 Clinical Trial ClinicalTrials.gov · COMPLETED, 2025
• Brain Mechanisms of Vagus Nerve Stimulation and Stress Reduction Training for Migraine ClinicalTrials.gov · COMPLETED, 2025
• A Phase 2 Study of the Safety and Effectiveness of a Single Oral Dose of NXN 188 for the Treatment of Moderate to Severe Migraine Headache With Aura ClinicalTrials.gov · COMPLETED, 2010
• A Phase IIa, Multicenter, Randomized, Placebo-controlled Clinical Trial to Study the Safety and Efficacy of MK0974 for Migraine Prophylaxis in Patients With Episodic Migraine ClinicalTrials.gov · TERMINATED, 2009
• Effects of Progressive Muscle Relaxation Training Applied in Addition to Aerobic Exercise Training in Individuals With Migraine Diagnosis ClinicalTrials.gov · COMPLETED, 2025
• Mindfulness-Based Intervention for Adolescents With Chronic Migraine ClinicalTrials.gov · COMPLETED, 2025
• Presence of Signs of Central Sensitization in Episodic and Chronic Migraine - a Cross Sectional Study ClinicalTrials.gov · COMPLETED, 2022
• Phase I Pharmacokinetic and Safety Study of Intravenous Topiramate in Adult Patients ClinicalTrials.gov · COMPLETED, 2010
• A Randomized, Double-Blind, Single-Dose Study, Placebo-Controlled Evaluation of the Safety and Efficacy of Intravenous Lornoxicam in the Acute Treatment of the Headache of Migraine ClinicalTrials.gov · COMPLETED, 2006
• A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of SPN-538 as a Therapy for the Prevention of Migraine in Subjects Ages 6-11 Years ClinicalTrials.gov · TERMINATED, 2023
• The Effect of Music Therapy on Episodic Migraine Patients Under the Care of Chronic Pain Department - A Pilot Trial ClinicalTrials.gov · COMPLETED, 2019
• A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine (Progress) ClinicalTrials.gov · COMPLETED, 2022
• A Randomized, Double-blind Comparison of Single Dose Prochlorperazine Versus Acetaminophen, Aspirin and Caffeine for the Treatment of Acute Migraine in the Emergency Department ClinicalTrials.gov · TERMINATED, 2014
• BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine ClinicalTrials.gov · COMPLETED, 2018
• A Pilot Randomized Controlled Trial to Test the Complementary Therapeutic Efficacy of Tai Chi for the Prophylaxis of Episodic Migraine in Chinese Women ClinicalTrials.gov · COMPLETED, 2018
• A Single Blind, Placebo Controlled, Multi-Centre Study to Investigate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamics of the TRPV1 Antagonist SB-705498 Against the Pain of Acute Migraine ClinicalTrials.gov · COMPLETED
• Acute Effect of Immersive VR Technology on Postural Control and Reaction Time in Young Adults: a Randomized Controlled Trial ClinicalTrials.gov · COMPLETED, 2026
• Long-term Efficacy of Transcranial Direct Current Stimulation in Chronic Migraine With Medication Overuse: a Phase III, Placebo Controlled, Randomised Clinical Trial (Edisom) ClinicalTrials.gov · COMPLETED, 2018
• A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Naratriptan Hydrochloride 2.5 mg Tablets Under Fasted Conditions ClinicalTrials.gov · COMPLETED, 2007
• A Phase 1, Open Label, Single-Dose Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine ClinicalTrials.gov · COMPLETED, 2014
• ONSTIM: Occipital Nerve Stimulation for the Treatment of Intractable Migraine ClinicalTrials.gov · COMPLETED, 2011
• Greater Occipital and Supraorbital Nerve Blockade For The Preventive Treatment of Migraine ClinicalTrials.gov · COMPLETED, 2016
• Identifying Therapeutic Factors in an 8-Week (30 Hour) Mindfulness-Based Stress Reduction (MBSR) Program ClinicalTrials.gov · COMPLETED, 2012
• Assessment and Prevention of Menstrual Migraine: Phase 1-prospective Survey of Self-identified Menstrual Migraine. Phase 2-prevention of Menstrual Migraine With Relpax ClinicalTrials.gov · COMPLETED
• The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache ClinicalTrials.gov · COMPLETED, 2013
• A Phase 3, Long-Term, Open-Label Safety Study of LY2951742 (Galcanezumab) in Japanese Patients With Migraine ClinicalTrials.gov · COMPLETED, 2019
• Drug and Non-Drug Treatment of Severe Migraine ClinicalTrials.gov · COMPLETED, 2005
• Consequences of a Brain Lesion or of Migraine on Auditory Processing: Attention, Memory and Emotion ClinicalTrials.gov · COMPLETED, 2020
• Effect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migraine Without Aura: A Randomized Double-Blind Two-Way Crossover Study ClinicalTrials.gov · COMPLETED, 2025
• The Effect of Connective Tissue Massage in Patients With Migraine ClinicalTrials.gov · COMPLETED, 2019
• Comparison of Greater Occipital Nerve Blockade and Sphenopalatine Ganglion Blockade in Patients With Episodic Migraine ClinicalTrials.gov · COMPLETED, 2024
• Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine: A Randomized Double-Blind Two-Way Crossover Study ClinicalTrials.gov · COMPLETED, 2023
• Migraine Inducing Effect of Levcromakalim in Patients With Migraine With Aura ClinicalTrials.gov · COMPLETED, 2023
• A Nutritional Intervention for Migraines ClinicalTrials.gov · COMPLETED, 2012
• A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-FInding Study of Elismetrep (K-304) in the Treatment of Acute Migraine ClinicalTrials.gov · COMPLETED, 2025
• A Phase I, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 334 in Healthy Subjects and Migraine Patients ClinicalTrials.gov · COMPLETED, 2013
• Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine Pain ClinicalTrials.gov · COMPLETED, 2021
• Bilateral Sphenopalatine Ganglion Block With or Without Bilateral Greater Occipital Nerve Block for Treatment of Obstetric Post-Dural Puncture Headache After Spinal Anesthesia ClinicalTrials.gov · COMPLETED, 2022
• Physiological Changes Induced With SPG Stimulation in Migraine Patients - Amendment to the Pathway M-1 Trial ClinicalTrials.gov · COMPLETED, 2016
• An Case-controlled Randomized Study to the Efficacy of Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis ClinicalTrials.gov · COMPLETED, 2015
• Kinetic Study Of Supplementation With The Enzyme Diamine Oxidase In Patients With Histamine Intolerance ClinicalTrials.gov · COMPLETED, 2024
• Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine (The KSPN Migraine Study) ClinicalTrials.gov · COMPLETED, 2014
• Identification of Predictors of Treatment Response and Innovative Therapeutic Strategies Based on Non-Invasive Brain Stimulation in Patients With Chronic Migraine and Medication Overuse ClinicalTrials.gov · COMPLETED, 2026
• Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON) ClinicalTrials.gov · COMPLETED, 2024
• Improved Treatment Course for Patients With Migraine and Tension-type Headache ClinicalTrials.gov · COMPLETED, 2021
• The CHECK Trial: A Comparison of Headache Treatment in the Emergency Department: Compazine Versus Ketamine. A Multi-Center, Randomized, Double-Blind, Clinical Control Trial ClinicalTrials.gov · TERMINATED, 2017
• Greater Occipital Nerve Pulsed Radiofrequency for the Treatment of Combined Migraine and Cervicogenic Headache (New Approach): Randomized Clinical Trial ClinicalTrials.gov · COMPLETED, 2023
• The Effect of Histamine H1 Receptor Antagonist, Clemastin, on PACAP38 Induced Headache in Migraine Patients ClinicalTrials.gov · COMPLETED, 2016
• Effectiveness of a Structured Group Intervention Based on Pain Neuroscience Education for Patients With Fibromyalgia in Primary Care: a Multicenter Randomized Open-label Controlled Trial ClinicalTrials.gov · COMPLETED, 2018
• Phase II/III: Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Trial of BHV-3500 for the Acute Treatment of Migraine ClinicalTrials.gov · COMPLETED, 2019
• A Pilot, Phase 2a, Randomized, Double-blind, Placebo-controlled, Cross-over Clinical Study to Evaluate Safety and Efficacy of Sublingual MTX101 for the Acute Treatment of Migraine Headaches in Adults ClinicalTrials.gov · COMPLETED, 2025
• Catheter-directed Foam Sclerotherapy With Tumescence of the Great Saphenous Vein Versus Ultrasound Guided Foam Sclerotherapy: Randomised Controlled Trial ClinicalTrials.gov · COMPLETED, 2017
• A Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 333 in Healthy Subjects and Subjects With Migraines ClinicalTrials.gov · COMPLETED, 2014
• Abnormal thalamocortical network dynamics in migraine Neurology, 2019
• Structural and Functional Brain Changes in Migraine Pain and Therapy, 2021
• Association of Migraine With Aura and Other Risk Factors With Incident Cardiovascular Disease in Women Journal of the American Medical Association (JAMA), 2020
• Pooled Analysis of PFO Occluder Device Trials in Patients With PFO and Migraine Journal of the American College of Cardiology, 2021